Nucleoporins and nucleocytoplasmic transport in hematologic malignancies

被引:42
|
作者
Takeda, Akiko [1 ]
Yaseen, Nabeel R. [1 ]
机构
[1] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
关键词
Nucleoporin; NUP98; NUP214; CRM1; XPO1; Leukemia; Acute myeloid leukemia; Acute lymphoblastic leukemia; Nuclear export; Nucleocytoplasmic transport; ACUTE MYELOID-LEUKEMIA; NUCLEAR-PORE COMPLEX; ACUTE LYMPHOBLASTIC-LEUKEMIA; MESSENGER-RNA EXPORT; ACUTE UNDIFFERENTIATED LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; HEMATOPOIETIC STEM-CELLS; ACUTE MEGAKARYOBLASTIC LEUKEMIA; GENE-EXPRESSION PATTERN; NUP214-ABL1 FUSION GENE;
D O I
10.1016/j.semcancer.2014.02.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hematologic malignancies are often associated with chromosomal rearrangements that lead to the expression of chimeric fusion proteins. Rearrangements of the genes encoding two nucleoporins, NUP98 and NUP214, have been implicated in the pathogenesis of several types of hematologic malignancies, particularly acute myeloid leukemia. NUP98 rearrangements result in fusion of an N-terminal portion of NUP98 to one of numerous proteins. These rearrangements often follow treatment with topoisomerase II inhibitors and tend to occur in younger patients. They have been shown to induce leukemia in mice and to enhance proliferation and disrupt differentiation in primary human hematopoietic precursors. NUP214 has only a few fusion partners. DEK-NUP214 is the most common NUP214 fusion in AML; it tends to occur in younger patients and is usually associated with FLT3 internal tandem duplications. The leukemogenic activity of NUP214 fusions is less well characterized. Normal nucleoporins, including NUP98 and NUP214, have important functions in nucleocytoplasmic transport, transcription, and mitosis. These functions and their disruptions by oncogenic nucleoporin fusions are discussed. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 50 条
  • [21] Hematologic Malignancies of the Breast
    Alsadi, Alaa
    Murro, Diana
    Martyn, Colin
    Miller, Ira
    Gattuso, Paolo
    LABORATORY INVESTIGATION, 2015, 95 : 33A - 33A
  • [22] SUMO and Nucleocytoplasmic Transport
    Ptak, Christopher
    Wozniak, Richard W.
    SUMO REGULATION OF CELLULAR PROCESSES, 2ND EDITION, 2017, 963 : 111 - 126
  • [23] Nucleocytoplasmic transport in apoptosis
    E Ferrando-May
    Cell Death & Differentiation, 2005, 12 : 1263 - 1276
  • [24] Immunotherapy for Hematologic Malignancies
    Craddock, Charles
    Friedberg, Jonathan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (05) : 343 - +
  • [25] Telomerase in hematologic malignancies
    Bruedigam, Claudia
    Lane, Steven W.
    CURRENT OPINION IN HEMATOLOGY, 2016, 23 (04) : 346 - 353
  • [26] Immunotherapy in hematologic malignancies
    Kansara, R. R.
    Speziali, C.
    CURRENT ONCOLOGY, 2020, 27 : S124 - S131
  • [27] The Microbiota in Hematologic Malignancies
    Yajing Song
    Bryan Himmel
    Lars Öhrmalm
    Peter Gyarmati
    Current Treatment Options in Oncology, 2020, 21
  • [28] Angiogenesis in hematologic malignancies
    Moehler, TM
    Ho, AD
    Goldschmidt, H
    Barlogie, B
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 45 (03) : 227 - 244
  • [29] Hematologic malignancies of childhood
    Head, David R.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 : S7 - S7
  • [30] Epigenetics in the hematologic malignancies
    Fong, Chun Yew
    Morison, Jessica
    Dawson, Mark A.
    HAEMATOLOGICA, 2014, 99 (12) : 1772 - 1783